Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Cardiotoxicity 1

Interventions

Razoxane 4Doxorubicin 4Dexrazoxane 4Vincristine 3Etoposide 3Radiotherapy 2Prednisone 2Methotrexate 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Bleomycin 2hydrocortisone hemisuccinate 1Watchful Waiting 1Trastuzumab 1Proton Therapy 1Observation 1Mercaptopurine 1Leucovorin 1Ifosfamide 1Hydrocortisone 1Enalapril 1Cytarabine 1Cyclophosphamide 1Cisplatin 1Carvedilol 1Asparaginase 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Cardiotoxicity × Enalapril × Clear all
NCT00003070 2014-08-05

Enalapril in Treating Heart Damage Patients Who Received Anthracycline Chemotherapy for Childhood Cancer

Children's Oncology Group

Phase 3 Completed
13 enrolled

Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡